id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2006-N-0237-0050,FDA,FDA-2006-N-0237,Reference re OMB Review Charging for IND Treatment Use Final Rule,Other,References (internal) (REF),2009-08-18T04:00:00Z,2009,8,2009-08-18T04:00:00Z,,2016-02-18T16:24:04Z,,0,0,0900006480a0b971
FDA-2006-N-0237-0049,FDA,FDA-2006-N-0237,Notice of Final Rule re Charging for Investigational Drugs Under an Investigational New Drug Application,Rule,Final Rule,2009-08-13T04:00:00Z,2009,8,2009-08-13T04:00:00Z,,2016-02-09T20:59:52Z,E9-19004,0,0,0900006480a08453